- Edward Davies
- 1New York
The conflicts of interest of members of the committees that decide which drugs should be available to people on Medicare are so poorly monitored that financial interests could be influencing decisions, claims a report from federal investigators.1
Medicare’s prescription drug program, known as Part D, provides optional drug benefits to more than 30 million beneficiaries of Medicare. The Centers for …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record








Social bookmarking